NDC 60505-0116

NDC 60505-0116

NDC 60505-0116 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 60505-0116
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 60505-0116-5 [60505011605]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075498
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-12
Marketing End Date2017-10-31

NDC 60505-0116-0 [60505011600]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075498
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-12
Marketing End Date2017-10-31

NDC 60505-0116-1 [60505011601]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075498
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2001-04-12
Marketing End Date2017-10-31

NDC 60505-0116-7 [60505011607]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA075498
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2001-04-12
Marketing End Date2017-10-31

Drug Details

Medicade Reported Pricing

60505011607 TERAZOSIN 2 MG CAPSULE

Pricing Unit: EA | Drug Type:

60505011605 TERAZOSIN 2 MG CAPSULE

Pricing Unit: EA | Drug Type:

60505011600 TERAZOSIN 2 MG CAPSULE

Pricing Unit: EA | Drug Type:
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.